Abstract
Pretibial myxedema (thyroid dermopathy), an uncommon autoimmune manifestation of Graves’ disease, is almost always associated with significant ophthalmopathy and may be a marker for an unusually prolonged or different course for the ophthalmopathy. However, it is not known if the response to therapy for eye disease is different in patients with pretibial myxedema. We compared the results of orbital decompression in 385 patients without and 52 patients with pretibial myxedema operated on between 1969 and 1989. Preoperative and postoperative characteristics of severe Graves’ ophthalmopathy did not differ in patients with or without pretibial myxedema except for slightly, but not significantly, more proptosis and diplopia in the pretibial myxedema group. In response to a 1989–1990 questionnaire (83% response rate, n=364), 89.1% without (n=319) and 88.9% with (n=45) pretibial myxedema reported satisfactory or acceptable appearance of the eyes. Self-assessment of visual acuity, eye comfort, diplopia, and overall rate of satisfaction with the status of the eyes did not differ between the groups. The presence of pretibial myxedema does not herald an unsatisfactory response to transantral orbital decompression.
Similar content being viewed by others
References
Kriss J.P. Pathogenesis and treatment of pretibial myxedema. Endocrinol. Metab. Clin. North Am. 16: 409, 1987.
Noppakun N., Bancheun K., Chandraprasert S. Unusual locations of localized myxedema in Graves’ disease. Arch. Dermatol. 122: 85, 1986.
Akasu F., Takazawa K., Akasu R., Onaya T. Localized myxedema on the nasal dorsum in a patient with Graves’ disease: report of a case. J. Endocrinol. Invest. 12: 717, 1989.
Cohen B.D., Benua R.S., Rawson R.W. Localized myxedema involving the upper extremities. Arch. Intern. Med. 111: 641, 1963.
Gimlette T.M.D. Pretibial myxoedema. Br. Med. J. 2: 348, 1960.
Lynch P.J., Maize J.C., Sisson J.C. Pretibial myxedema and nonthyrotoxic thyroid disease. Arch. Dermatol. 107: 107, 1973.
Cheung H.S., Nicoloff J.T., Kamiel M.B., Spolter L., Nimni M.E. Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema. J. Invest. Dermatol. 71: 12, 1978.
Wilson J.D., Foster D.W. Williams Textbook of Endocrinology, ed. 8. W.B. Saunders Company, Philadelphia, 1992.
Morris J.C. III, Hay I.D., Nelson R.E., Jiang N.-S. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin. Proc. 63: 707, 1988.
Beierwaltes W.H. Clinical correlation of pretibial myxedema with malignant exophthalmos. Ann. Intern. Med. 40: 968, 1954.
Walsh T.E., Ogura J.H. Transantral orbital decompression for malignant exophthalmos. Laryngoscope 67: 544, 1957.
MacCarty C.S., Kenefick T.P., McConahey W.M., Kearns T.P. Ophthalmopathy of Graves’ disease treated by removal of roof, lateral walls, and lateral sphenoid ridge: review of 46 cases. Mayo Clin. Proc. 45: 488, 1970.
DeSanto LW., Gorman C.A. Selection of patients and choice of operation for orbital decompression in Graves’ ophthalmopathy. Laryngoscope 83: 945, 1973.
Lipman L.M., Green D.E., Snyder N.J., Nelson J.C., Solomon D.H. Relationship of long-acting thyroid stimulator to the clinical features and course of Graves’ disease. Am. J. Med. 43: 486, 1967.
Kahaly G., Moncayo R., Stover C., Beyer J. Relationship of eye muscle antibodies with HLA phenotypes and thyroid-stimulating immunoglobulins in endocrine orbitopathy. Res. Exp. Med. 191: 137, 1991.
Werner S.C., Feind CR., Aida M. Graves’ disease and total thyroidectomy: progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation. N.Engl. J. Med. 276: 132, 1967.
Atta H.R., McCreath G., McKillop J.H., Forrester J.V., Thomson J.A., Wilson R., Gray H.W. Ophthalmopathy in early thyrotoxicosis-dashrelationship to thyroid receptor antibodies and effects of treatment. Scot. Med. J. 35: 41, 1990.
Kriss J.P., Pleshakov V., Chien J.R. Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema. J. Clin. Endocrinol. Metab. 24: 1005, 1964.
Schermer D.R., Roenigk H.H. Jr., Schumacher O.P., McKenzie J.M. Relationship of long-acting thyroid stimulator to pretibial myxedema. Arch. Dermatol. 102: 62, 1970.
Author information
Authors and Affiliations
Additional information
Supported in part by Research Grant EY 08039 from the National Institutes of Health and by a grant from Research to Prevent Blindness, Inc., New York, New York.
Rights and permissions
About this article
Cite this article
Fatourechi, V., Garrity, J.A., Bartley, G.B. et al. Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema. J Endocrinol Invest 16, 433–437 (1993). https://doi.org/10.1007/BF03348875
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348875